Cyclopharm Limited (ASX:CYC)
Australia
· Delayed Price · Currency is AUD 1.130
-0.010 (-0.88%)
Apr 28, 2025, 4:10 PM AEST
Cyclopharm Revenue
In the year 2024, Cyclopharm had annual revenue of 27.57M AUD with 4.68% growth. Cyclopharm had revenue of 14.37M in the half year ending December 31, 2024, with 6.87% growth.
Revenue
27.57M
Revenue Growth
+4.68%
P/S Ratio
4.55
Revenue / Employee
290.24K
Employees
95
Market Cap
125.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.57M | 1.23M | 4.68% |
| Dec 31, 2023 | 26.34M | 1.48M | 5.97% |
| Dec 31, 2022 | 24.85M | 4.86M | 24.30% |
| Dec 31, 2021 | 20.00M | 2.31M | 13.09% |
| Dec 31, 2020 | 17.68M | 668.06K | 3.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |